Not investment advice. Educational platform. See Disclaimer.
NASDAQ: OACC
Oaktree Acquisition Corp. III Life Sciences
Financial Services | Shell Companies
No licensed closing price on file for OACC. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a shell company. Figures from SEC EDGAR; updated 2026-10-20 12:31 UTC.
What Oaktree Acquisition Corp. III Life Sciences does
The company is a blank check company incorporated in the Cayman Islands in June 2024, formed to pursue a merger or business combination with an operating business. It has completed its initial public offering and is currently searching for a target company but has not yet selected one or generated any operating revenues. The company intends to focus on healthcare or healthcare-related industries, particularly targeting companies in biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America, Britain, or Europe.
Summarized from Oaktree Acquisition Corp. III Life Sciences’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗